全文获取类型
收费全文 | 1150篇 |
免费 | 64篇 |
国内免费 | 8篇 |
专业分类
儿科学 | 37篇 |
妇产科学 | 74篇 |
基础医学 | 231篇 |
口腔科学 | 12篇 |
临床医学 | 106篇 |
内科学 | 188篇 |
皮肤病学 | 17篇 |
神经病学 | 45篇 |
特种医学 | 84篇 |
外科学 | 247篇 |
综合类 | 19篇 |
预防医学 | 49篇 |
眼科学 | 24篇 |
药学 | 37篇 |
中国医学 | 1篇 |
肿瘤学 | 51篇 |
出版年
2022年 | 10篇 |
2021年 | 12篇 |
2020年 | 20篇 |
2019年 | 20篇 |
2018年 | 24篇 |
2017年 | 15篇 |
2016年 | 17篇 |
2015年 | 17篇 |
2014年 | 32篇 |
2013年 | 38篇 |
2012年 | 43篇 |
2011年 | 51篇 |
2010年 | 32篇 |
2009年 | 57篇 |
2008年 | 63篇 |
2007年 | 72篇 |
2006年 | 43篇 |
2005年 | 37篇 |
2004年 | 24篇 |
2003年 | 31篇 |
2002年 | 25篇 |
2001年 | 27篇 |
2000年 | 23篇 |
1999年 | 18篇 |
1998年 | 18篇 |
1997年 | 17篇 |
1996年 | 23篇 |
1995年 | 17篇 |
1994年 | 14篇 |
1993年 | 20篇 |
1992年 | 19篇 |
1991年 | 13篇 |
1990年 | 13篇 |
1989年 | 18篇 |
1988年 | 19篇 |
1987年 | 17篇 |
1986年 | 13篇 |
1985年 | 20篇 |
1984年 | 11篇 |
1983年 | 9篇 |
1982年 | 8篇 |
1980年 | 10篇 |
1978年 | 7篇 |
1977年 | 7篇 |
1973年 | 11篇 |
1971年 | 6篇 |
1936年 | 29篇 |
1935年 | 29篇 |
1934年 | 33篇 |
1933年 | 23篇 |
排序方式: 共有1222条查询结果,搜索用时 296 毫秒
101.
Schleckat Pauschardt Dietrich Zorn Henrich Schmidt W. Schmidt Langenbeck Valentin A. Hermann Müller Eckstein Dinkler Stefan Rosenhagen 《Journal of molecular medicine (Berlin, Germany)》1934,13(48):1728-1731
Ohne Zusammenfassung 相似文献
102.
Schmidt A. Hermann Müller Pendl Kahlstorf Fuchs Uhlmann Versé W. Fischer Rosenhagen Dinkler Zorn 《Journal of molecular medicine (Berlin, Germany)》1936,15(21):761-764
Ohne Zusammenfassung 相似文献
103.
Zorn Fuchs Mündel Schleckat Klose Dinkler Henrich Dietrich Schumacher Valentin Rosenhagen Langenbeck H. Boeters Meesmann 《Journal of molecular medicine (Berlin, Germany)》1935,14(18):651-656
Ohne Zusammenfassung 相似文献
104.
105.
IJ Webb ; CE Eickhoff ; AD Elias ; LJ Ayash ; CA Wheeler ; GN Schwartz ; GD Demetri ; KC Anderson 《Transfusion》1996,36(2):160-167
BACKGROUND: Peripheral blood progenitor cells (PBPCs) are commonly collected and used to reconstitute hematopoiesis after high-dose chemotherapy. However, strategies for optimal collection and assessment of leukapheresis components are not standardized. STUDY DESIGN and METHODS: Hematopoietic progenitor cell assays were performed on 369 leukapheresis components collected from 95 patients who had received doxorubicin-based chemotherapy and/or granulocyte-colony-stimulating factor (G-CSF). Precollection patient hematologic values, leukapheresis collection values, component hematopoietic progenitor cell assays, and patient outcome measures were summarized. The kinetics of mononuclear cell (MNC) and PBPC mobilization were assessed among four patient groups. RESULTS: Patient group was a significant predictor of the peripheral blood MNC count on the day of collection (p<0.0001), and that value was a significant predictor of granulocyte-macrophage– colony-forming unit (CFU-GM) yield (p<0.0001). This relationship between the peripheral blood MNC count on the day of collection and CFU- GM yield differed according to patient group (p<0.0001). CFU-GM made up a larger fraction of peripheral blood MNCs collected from patients who received chemotherapy plus G-CSF than collected from those who received G-CSF alone. Moreover, the peripheral blood MNC count and the corresponding CFU-GM yield increased significantly on consecutive days of collection in patient groups receiving chemotherapy and G-CSF but were unchanged or decreased in patients receiving G-CSF alone. CONCLUSION: The relationship between peripheral blood MNC count and leukapheresis component CFU-GM yield differed significantly between patients who received chemotherapy and G-CSF and those who received G- CSF alone for the mobilization of PBPCs. Patient peripheral blood MNC count and component CFU-GM yield are useful for both assessing and suggesting revisions to PBPC mobilization and collection strategies. 相似文献
106.
Zorn E Miklos DB Floyd BH Mattes-Ritz A Guo L Soiffer RJ Antin JH Ritz J 《The Journal of experimental medicine》2004,199(8):1133-1142
We examined the immune response to DBY, a model H-Y minor histocompatibility antigen (mHA) in a male patient with chronic graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplant from a human histocompatibility leukocyte antigen (HLA)-identical female sibling. Patient peripheral blood mononuclear cells were screened for reactivity against a panel of 93 peptides representing the entire amino acid sequence of DBY. This epitope screen revealed a high frequency CD4(+) T cell response to a single DBY peptide that persisted from 8 to 21 mo after transplant. A CD4(+) T cell clone displaying the same reactivity was established from posttransplant patient cells and used to characterize the T cell epitope as a 19-mer peptide starting at position 30 in the DBY sequence and restricted by HLA-DRB1*1501. Remarkably, the corresponding X homologue peptide was also recognized by donor T cells. Moreover, the T cell clone responded equally to mature HLA-DRB1*1501 male and female dendritic cells, indicating that both DBY and DBX peptides were endogenously processed. After transplant, the patient also developed antibodies that were specific for recombinant DBY protein and did not react with DBX. This antibody response was mapped to two DBY peptides beginning at positions 118 and 536. Corresponding DBX peptides were not recognized. These studies provide the first demonstration of a coordinated B and T cell immune response to an H-Y antigen after allogeneic transplant. The specificity for recipient male cells was mediated by the B cell response and not by donor T cells. This dual DBX/DBY antigen is the first mHA to be identified in the context of chronic GVHD. 相似文献
107.
Anne-Marie Pons Nathalie Zorn David Vignon Franois Delalande Alain Van Dorsselaer Gilles Cottenceau 《Antimicrobial agents and chemotherapy》2002,46(1):229-230
The pore-forming microcin E492 was purified by solid-phase extraction and reversed-phase high-pressure liquid chromatography. Its molecular mass was 7,886 Da. The entire 84-amino-acid sequence was determined. There is no postranslational modification in the secreted microcin, and the sequence has homologies with the sequence of the microcin colicin V. 相似文献
108.
109.